NCT03407196View on ClinicalTrials.gov

Dapagliflozin in Type 2 Diabetes Patients, a Retrospective Cohort Study From Turkey

CompletedOBSERVATIONAL

Enrollment

1,683

Participants

Timeline

Start Date

May 24, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

February 28, 2018

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Forxiga

Oral antidiabetics

Trial Locations (1)

06280

Keçiören Training and Research Hospital, Ankara

Sponsors

Lead Sponsor

AstraZeneca Turkey

All Listed Sponsors

collaborator

Optimum Contract Research Organization, Turkey

UNKNOWN

lead

AstraZeneca Turkey

INDUSTRY